Kim Nam Hee, Chang Yoosoo, Ryu Seungho, Sohn Chong Il
Division of Gastroenterology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
J Neurogastroenterol Motil. 2025 Jan 31;31(1):54-62. doi: 10.5056/jnm24058.
BACKGROUND/AIMS: We aim to compare the remission of erosive esophagitis (EE) among individuals with different phenotypes based on their metabolic health and obesity status and investigate the impact of changes in metabolic health on the EE remission.
Asymptomatic adults (n = 16 845) with EE at baseline, who underwent follow-up esophagogastroduodenoscopy (EGD) were categorized into 4 groups as follows: metabolically healthy (MH) nonobese, metabolically unhealthy (MU) nonobese, MH obese, and MU obese. EE was defined as grade A or higher mucosal breaks observed using esophagogastroduodenoscopy.
During a median follow-up of 2.2 years, the remission rates of EE were 286.4/10, 260.1/10, 201.5/10, and 219.9/10 person-years in MH nonobese, MU nonobese, MH obese, and MU obese groups, respectively. Multivariate-adjusted hazard ratios (95% CI) for EE remission among the MH nonobese, MU nonobese, and MH obese groups versus that of the MU obese group were 1.30 (1.23-1.37), 1.17 (1.12-1.23), and 0.98 (0.90-1.06), respectively, whereas those of the persistent MH, progression of MH to MU, and remission of MU to MH compared with the persistent MU group were 1.37 (1.23-1.52), 1.15 (1.01-1.30), and 1.28 (1.12-1.46), respectively. Increased EE remission in the persistent MH group was consistently observed in individuals with and without obesity (or abdominal obesity).
Metabolic health and nonobesity independently and favorably impact EE remission. Maintaining normal weight and healthy metabolic status may contribute to EE remission.
背景/目的:我们旨在比较不同表型个体(基于其代谢健康状况和肥胖状态)中糜烂性食管炎(EE)的缓解情况,并研究代谢健康变化对EE缓解的影响。
基线时患有EE且接受随访食管胃十二指肠镜检查(EGD)的无症状成年人(n = 16845)被分为以下4组:代谢健康(MH)非肥胖、代谢不健康(MU)非肥胖、MH肥胖和MU肥胖。EE定义为通过食管胃十二指肠镜检查观察到的A级或更高等级的黏膜破损。
在中位随访2.2年期间,MH非肥胖、MU非肥胖、MH肥胖和MU肥胖组中EE的缓解率分别为每10人年286.4例、260.1例、201.5例和219.9例。与MU肥胖组相比,MH非肥胖、MU非肥胖和MH肥胖组中EE缓解的多变量调整风险比(95%CI)分别为1.30(1.23 - 1.37)、1.17(1.12 - 1.23)和0.98(0.90 - 1.06),而与持续MU组相比,持续MH组、MH进展为MU组和MU缓解为MH组的风险比分别为1.37(1.23 - 1.52)、1.15(1.01 - 1.30)和1.28(1.12 - 1.46)。在有肥胖和无肥胖(或腹型肥胖)的个体中均一致观察到持续MH组中EE缓解增加。
代谢健康和非肥胖对EE缓解具有独立且有利的影响。维持正常体重和健康的代谢状态可能有助于EE缓解。